Month: June 2025

Contract development and manufacturing organization Bionova Scientific is entering the advanced therapy manufacturing space by installing its third FlexFactory platform from Cytiva to meet rising demand for genomic medicines. Cytiva…

Lotte Biologics has signed a contract manufacturing agreement with Ottimo Pharma to produce antibody drug substance for Ottimo’s investigational cancer therapy Jankistomig. The agreement was formalized this week during the 2025 BIO…

Global contract development and manufacturing organization Recipharm announced that it has secured product development contracts that strengthen its position in blow-fill-seal (BFS) technology, a single continuous process within a sterile closed system…

European biotechs have historically struggled to find capital on the continent, but the funding ecosystem now aims to scale up. he science is brilliant in Europe, but the translation is…

Global biopharma company UCB has announced plans to build a new biologics manufacturing facility in the United States, a move expected to deliver an estimated $5 billion in economic impact. The site…

The microgravity environment enables the production of purer crystals, resulting in more concentrated therapies. BioOrbit aims to kick off pre-clinical trials to study protein crystals for monoclonal antibodies (mAbs) produced…

AstraZeneca has joined the long list of big pharma companies enlisting the services of Chinese biotechs, signing a deal worth up to $5.2bn with CSPC Pharmaceuticals to research chronic disease…